Back to top

genetics: Archive

Sweta Jaiswal, FRM

A Comprehensive Guide to Genomic ETFs

Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

BEAMPositive Net Change EDITPositive Net Change PBEPositive Net Change NTLAPositive Net Change CRSPPositive Net Change ARKGPositive Net Change GNOMPositive Net Change IDNAPositive Net Change

Sweta Jaiswal, FRM

Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

REGNPositive Net Change BEAMPositive Net Change EDITPositive Net Change NTLAPositive Net Change CRSPPositive Net Change ARKGPositive Net Change GNOMPositive Net Change IDNAPositive Net Change

Kevin Cook

Bear of the Day: Guardant Health (GH)

Cancer detection innovator with liquid biopsy saw analysts slash estimates as R&D investment costs rise

GHPositive Net Change EXASPositive Net Change

Zacks Equity Research

Moving Average Crossover Alert: Passage Bio (PASG)

Passage Bio (PASG) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

PASGPositive Net Change

Kevin Cook

Bear of the Day: CRISPR Therapeutics (CRSP)

Gene editors got a big boost recently from sickle cell potential and Cathie Wood's thematic investing

CRSPPositive Net Change EDITPositive Net Change ARKKPositive Net Change NTLAPositive Net Change ARKGPositive Net Change

Kevin Cook

Bear of the Day: Illumina (ILMN)

Maker of premier next-gen genomic sequencing technology lowers guidance but shares make new highs

ILMNPositive Net Change EDITPositive Net Change NVTAPositive Net Change ARKKPositive Net Change ARKGPositive Net Change

Sweta Jaiswal, FRM

5 Top-Performing ARK ETFs Worth Your Attention Now

Here we highlight some ETFs from the house of ARK Investment Management that have gained more than 100% in the past year for our investors to consider.

TDOCPositive Net Change PYPLPositive Net Change SQPositive Net Change ARKQPositive Net Change ARKWPositive Net Change ARKKPositive Net Change CRSPPositive Net Change ROKUPositive Net Change ARKGPositive Net Change GBTCPositive Net Change ARKFPositive Net Change

Kevin Cook

Bull of the Day: Meridian Bioscience (VIVO)

Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations

VIVONegative Net Change HOLXPositive Net Change QDELNegative Net Change EDITPositive Net Change CRSPPositive Net Change

Daniel Laboe

The Innovative Future Of ETFs

Ark Invest is driving a new generation of actively managed ETFs

TSLAPositive Net Change SQPositive Net Change ROKUPositive Net Change PRLBPositive Net Change NVTAPositive Net Change CRSPPositive Net Change ARKKPositive Net Change

Sweta Jaiswal, FRM

Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

PBEPositive Net Change ARKGPositive Net Change GNOMPositive Net Change IDNAPositive Net Change